Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 103Leukemia 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Lymphoma 29Prostatic Neoplasms 28Leukemia, Monocytic, Acute 26Leukemia, Erythroblastic, Acute 23Congenital Abnormalities 23Leukemia, Myelomonocytic, Acute 22Leukemia, Megakaryoblastic, Acute 21Myelodysplastic Syndromes 17Lymphoma, Non-Hodgkin 17Lymphoma, Follicular 17Lymphoma, Large B-Cell, Diffuse 16Recurrence 14Lymphoma, Large-Cell, Immunoblastic 10Leukemia, Lymphocytic, Chronic, B-Cell 10Leukemia, Biphenotypic, Acute 9Lymphoma, Mantle-Cell 8Burkitt Lymphoma 7Breast Neoplasms 7Anemia, Refractory, with Excess of Blasts 6Neoplasms 5Leukemia, Promyelocytic, Acute 5Hodgkin Disease 5Blast Crisis 5Ovarian Neoplasms 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Eosinophilic, Acute 4Leukemia, Basophilic, Acute 4

Interventions

fludarabine phosphate 6Whole-Body Irradiation 5Mycophenolic Acid 5fludarabine 4Peripheral Blood Stem Cell Transplantation 4Cyclosporins 4Cyclosporine 4Cyclophosphamide 4venetoclax 3ruxolitinib 3Cytarabine 3Alemtuzumab 3itacitinib 2duvelisib 2carmustine, poliferprosan 20 drug combination 2Stem Cell Transplantation 2Sirolimus 2Melphalan 2Etoposide 2Carmustine 2thymoglobulin 1romidepsin 1niraparib 1nelarabine 1letermovir 1ibrutinib 1Tacrolimus 1Sensitivity and Specificity 1Mitoxantrone 1Lisaftoclax 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Prolymphocytic, T-Cell × Mitoxantrone × Clear all
NCT01186640 2022-01-05

Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)

German CLL Study Group

Phase 2 Completed
16 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Prolymphocytic, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡